Compare TTK HEALTHCARE with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AUROBINDO PHARMA TTK HEALTHCARE/
AUROBINDO PHARMA
 
P/E (TTM) x 18.9 9.7 194.8% View Chart
P/BV x 1.5 1.8 84.4% View Chart
Dividend Yield % 1.0 0.6 173.7%  

Financials

 TTK HEALTHCARE   AUROBINDO PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
AUROBINDO PHARMA
Mar-19
TTK HEALTHCARE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,215830 146.4%   
Low Rs610527 115.7%   
Sales per share (Unadj.) Rs444.4333.9 133.1%  
Earnings per share (Unadj.) Rs17.240.4 42.7%  
Cash flow per share (Unadj.) Rs27.651.8 53.4%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Dividend yield (eoy) %0.50.4 148.7%  
Book value per share (Unadj.) Rs177.9237.1 75.1%  
Shares outstanding (eoy) m14.13585.91 2.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.0 101.1%   
Avg P/E ratio x52.916.8 314.7%  
P/CF ratio (eoy) x33.013.1 251.9%  
Price / Book Value ratio x5.12.9 179.2%  
Dividend payout %29.06.2 468.0%   
Avg Mkt Cap Rs m12,894397,569 3.2%   
No. of employees `0002.317.9 12.9%   
Total wages/salary Rs m1,30725,849 5.1%   
Avg. sales/employee Rs Th2,715.710,956.9 24.8%   
Avg. wages/employee Rs Th565.31,447.7 39.0%   
Avg. net profit/employee Rs Th105.41,324.3 8.0%   
INCOME DATA
Net Sales Rs m6,279195,636 3.2%  
Other income Rs m781,553 5.0%   
Total revenues Rs m6,356197,189 3.2%   
Gross profit Rs m49639,519 1.3%  
Depreciation Rs m1476,680 2.2%   
Interest Rs m342,626 1.3%   
Profit before tax Rs m39331,767 1.2%   
Minority Interest Rs m027 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-881 0.0%   
Tax Rs m1497,269 2.0%   
Profit after tax Rs m24423,645 1.0%  
Gross profit margin %7.920.2 39.1%  
Effective tax rate %37.922.9 165.8%   
Net profit margin %3.912.1 32.1%  
BALANCE SHEET DATA
Current assets Rs m2,717153,645 1.8%   
Current liabilities Rs m1,571120,429 1.3%   
Net working cap to sales %18.317.0 107.5%  
Current ratio x1.71.3 135.6%  
Inventory Days Days32135 23.8%  
Debtors Days Days4764 73.2%  
Net fixed assets Rs m991103,909 1.0%   
Share capital Rs m141586 24.1%   
"Free" reserves Rs m2,373138,322 1.7%   
Net worth Rs m2,514138,908 1.8%   
Long term debt Rs m31,800 0.2%   
Total assets Rs m4,158264,544 1.6%  
Interest coverage x12.613.1 96.3%   
Debt to equity ratio x00 10.4%  
Sales to assets ratio x1.50.7 204.2%   
Return on assets %6.79.9 67.2%  
Return on equity %9.717.0 56.9%  
Return on capital %16.923.8 71.1%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22597,316 0.2%   
Fx outflow Rs m7140,589 0.2%   
Net fx Rs m15456,727 0.3%   
CASH FLOW
From Operations Rs m17316,220 1.1%  
From Investments Rs m97-28,768 -0.3%  
From Financial Activity Rs m-30719,191 -1.6%  
Net Cashflow Rs m-386,656 -0.6%  

Share Holding

Indian Promoters % 65.4 54.1 120.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 8.0 46.5%  
FIIs % 5.2 27.7 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.2 252.9%  
Shareholders   12,723 69,601 18.3%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Nov 18, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - LUPIN COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS